Cezentry Trademark Details
Word Mark | Cezentry |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Serial Number | 77183300 |
---|---|
Status Date | Monday, August 23, 2010 |
Filing Date | Monday, August 23, 2010 |
Attorney | Matthew Pater |
Correspondent
Matthew Pater
PFIZER INC.
150 EAST 42ND STREET
LEGAL DIVISION, TRADEMARKS, 5TH FLOOR
NEW YORK NY 10017
PFIZER INC.
150 EAST 42ND STREET
LEGAL DIVISION, TRADEMARKS, 5TH FLOOR
NEW YORK NY 10017
Case File Statements
Goods & Services | Pharmaceutical preparations for the treatment of infectious diseases, immunological disorders, viral disorders, pharmaceutical preparations, namely, preparations for the treatment of HIV and AIDS |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, May 22, 2007 |
Primary Code | 005 |
Trademark Timeline
-
May 17 2007Trademark application filed with USPTO
-
May 22 2007New Application Entered In Tram
-
Aug 20 2007Assigned To Examiner
-
Aug 23 2007Approved For Pub - Principal Register
-
Sep 25 2007Law Office Publication Review Completed
-
Sep 25 2007Assigned To Lie
-
Oct 10 2007Notice of Publication
-
Oct 30 2007Published For Opposition
-
Jan 22 2008Noa Mailed - Sou Required From Applicant
-
Jul 21 2008Extension 1 Granted
-
Jul 21 2008Extension 1 Filed
-
Jul 21 2008Teas Extension Received
-
Dec 11 2008Extension 2 Filed
-
Dec 11 2008Teas Extension Received
-
Dec 29 2008Extension 2 Granted
-
Dec 29 2008Case Assigned To Intent To Use Paralegal
-
Jun 18 2009Extension 3 Filed
-
Jun 18 2009Teas Extension Received
-
Jun 22 2009Extension 3 Granted
-
Jan 11 2010Extension 4 Filed
-
Jan 11 2010Teas Extension Received
-
Jan 19 2010Extension 4 Granted
-
Aug 23 2010Abandonment Notice Mailed - No Use Statement Filed
-
Aug 23 2010Abandonment - No Use Statement Filed